INTERNATIONAL PATENT: REMEDY PHARMACEUTICALS, INC. FILES APPLICATION FOR "METHODS OF TREATING ISCHEMIC STROKE AT RISK FOR CEREBRAL OR CEREBELLAR EDEMA USING A SUR1-TRPM4 CHANNEL INHIBITOR"

GENEVA, Oct. 14 -- REMEDY PHARMACEUTICALS, INC. (233 Broadway, 17th FloorNew York, New York 10279) filed a patent application (PCT/US2025/013371) for "METHODS OF TREATING ISCHEMIC STROKE AT RISK FOR CEREBRAL OR CEREBELLAR EDEMA USING A SUR1-TRPM4 CHANNEL INHIBITOR" on Jan 28, 2025. With publication no. WO/2025/212156, the details related to the patent application was published on Oct 09, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): JACOBSON, Sven Martin (c/o REMEDY PHARMACEUTICALS, INC.233 Broadway, 17th FloorNew York, New York 10279), MACALLISTER, Thomas W. (c/o REMEDY PHARMACEUTICALS, I...